Clinical trial · Interventional
Chemotherapy With DNA Damaging Agents In Colorectal Cancer
Phase 1 Study Of The Efficacy Of Chemotherapy With DNA Damaging Agents Versus Surgery In Colorectal Cancer
NCT01456923CI-TRIAL-00005671completedPhase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Chemotherapy Treatment alone with DNA damaging drugs might be as effective as chemotherapy combined with surgery in colorectal cancer (CRC) avoiding surgery complications.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Only chemotherapy treatment for study cohort | Other | — | UNRESOLVED |
| surgery | Procedure | — | UNRESOLVED |
| Treatment with chemotherapy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Control (chemotherapy and surgery)
- description
- Patients treated with chemotherapy + surgery
- interventionNames
- Other: Treatment with chemotherapy
- Procedure: surgery
- type
- ACTIVE_COMPARATOR
- label
- Study
- description
- Patients treated only with chemotherapy
- interventionNames
- Other: Only chemotherapy treatment for study cohort
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: \- patients that did not underwent surgery Exclusion Criteria: \- patients that underwent surgery
References
Publications (0)
Data not yet available
No reference posted for this study.